CH390243A - Verfahren zur Herstellung von ungesättigten Halogensteroiden - Google Patents
Verfahren zur Herstellung von ungesättigten HalogensteroidenInfo
- Publication number
- CH390243A CH390243A CH943960A CH943960A CH390243A CH 390243 A CH390243 A CH 390243A CH 943960 A CH943960 A CH 943960A CH 943960 A CH943960 A CH 943960A CH 390243 A CH390243 A CH 390243A
- Authority
- CH
- Switzerland
- Prior art keywords
- preparation
- unsaturated halogen
- halogen steroids
- steroids
- unsaturated
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/69—Benzenesulfonamido-pyrimidines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DEM0042545 | 1959-08-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH390243A true CH390243A (de) | 1965-04-15 |
Family
ID=7304374
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH943960A CH390243A (de) | 1959-08-26 | 1960-08-19 | Verfahren zur Herstellung von ungesättigten Halogensteroiden |
Country Status (4)
| Country | Link |
|---|---|
| CH (1) | CH390243A (enrdf_load_stackoverflow) |
| FR (1) | FR297M (enrdf_load_stackoverflow) |
| GB (1) | GB951460A (enrdf_load_stackoverflow) |
| SE (1) | SE220104C1 (enrdf_load_stackoverflow) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3956349A (en) * | 1975-02-18 | 1976-05-11 | Syntex (U.S.A.) Inc. | Process for preparing 3-enol ethers of 11β-hydroxy-Δ4 -pregnene-3-ones and derivatives thereof |
-
1960
- 1960-08-19 CH CH943960A patent/CH390243A/de unknown
- 1960-08-26 GB GB29557/60A patent/GB951460A/en not_active Expired
- 1960-08-26 SE SE816760A patent/SE220104C1/sl unknown
- 1960-08-26 FR FR836861A patent/FR297M/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| FR297M (fr) | 1961-03-13 |
| SE220104C1 (enrdf_load_stackoverflow) | 1968-04-23 |
| GB951460A (en) | 1964-03-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH370197A (de) | Verfahren zur Herstellung von Actinospectacin | |
| CH387047A (de) | Verfahren zur Herstellung von Ketosidopurinen | |
| CH400144A (de) | Verfahren zur Herstellung von 16-Methylen-17a-hydroxy-progesteron-17-acylaten | |
| CH377811A (de) | Verfahren zur Herstellung von 16a-Niederalkyl-20-ketosteroiden | |
| CH404962A (de) | Verfahren zur Herstellung von Eupolyoxymethylenen | |
| CH396026A (de) | Verfahren zur Herstellung von Halogenalkylaminen | |
| CH383359A (de) | Verfahren zur Herstellung von 6B-Fluor- 4-3-ketosteroiden | |
| CH387606A (de) | Verfahren zur Herstellung von Tetrahydroxydibor | |
| CH399742A (de) | Verfahren zur Herstellung von Eupolyoxymethylenen | |
| CH440249A (de) | Verfahren zur Herstellung von Polychlorbenzonitrilen | |
| CH387029A (de) | Verfahren zur Herstellung von 9a-Fluor-11B-oxy-16a-methylprogesteron | |
| CH390243A (de) | Verfahren zur Herstellung von ungesättigten Halogensteroiden | |
| CH394188A (de) | Verfahren zur Herstellung von Acyloxy-dien-dion-Steroiden | |
| CH380730A (de) | Verfahren zur Herstellung von 4-Methoxy-2-methyl-6-sulfanilamidopyrimidin | |
| CH417595A (de) | Verfahren zur Herstellung von Alkyl-5-alkylisoxazol-3-carboxylaten | |
| CH416113A (de) | Verfahren zur Herstellung von Eupolyoxymethylenen | |
| CH372297A (de) | Verfahren zur Herstellung von 4-2-tert.-Aminomethyl-3-keto-steroiden | |
| CH409951A (de) | Verfahren zur Herstellung von 16-Alkylen-Steroiden | |
| CH380120A (de) | Verfahren zur Herstellung von 16-Halomethylsteroiden | |
| CH378344A (de) | Verfahren zur Herstellung von 2-Amino-anthrachinonen | |
| CH412841A (de) | Verfahren zur Herstellung von 2-Trifluormethylbenzophenon | |
| AT237203B (de) | Verfahren zur Herstellung von 16-Methylensteroiden | |
| CH421097A (de) | Verfahren zur Herstellung von 16-Methylsteroiden | |
| CH388949A (de) | Verfahren zur Herstellung von 17a-Hydroxy-16a-methyl-20-keto-Steroiden der 5a-Reihe | |
| CH386419A (de) | Verfahren zur Herstellung von 16,17-Methylen-20-ketosteroiden |